202 related articles for article (PubMed ID: 35613543)
21. Incidence and risk factors of preoperative venous thromboembolism and pulmonary embolism in patients with ovarian cancer.
Liang S; Tang W; Ye S; Xiang L; Wu X; Yang H
Thromb Res; 2020 Jun; 190():129-134. PubMed ID: 32361343
[TBL] [Abstract][Full Text] [Related]
22. Investigating the efficacy of tissue factor pathway inhibitor‑2 as a promising prognostic marker for ovarian cancer.
Maehana T; Kawaguchi R; Nishikawa K; Kawahara N; Yamada Y; Kimura F
Oncol Lett; 2024 Jul; 28(1):302. PubMed ID: 38774455
[TBL] [Abstract][Full Text] [Related]
23. Dynamics of D-dimer in non-small cell lung cancer patients receiving radical surgery and its association with postoperative venous thromboembolism.
Ke L; Cui S; Chen S; Hu B; Li H
Thorac Cancer; 2020 Sep; 11(9):2483-2492. PubMed ID: 32657038
[TBL] [Abstract][Full Text] [Related]
24. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
Dujardin RWG; Hilderink BN; Haksteen WE; Middeldorp S; Vlaar APJ; Thachil J; Müller MCA; Juffermans NP
Thromb Res; 2020 Dec; 196():308-312. PubMed ID: 32977128
[TBL] [Abstract][Full Text] [Related]
25. Superior Predictive Value of D-Dimer to the Padua Prediction Score for Venous Thromboembolism in Inpatients with AECOPD: A Multicenter Cohort Study.
Zhou C; Guang Y; Luo Y; Ge H; Wei H; Liu H; Zhang J; Pan P; Zhang J; Peng L; Aili A; Liu Y; Pu J; Zhong X; Wang Y; Yi Q; Zhou H;
Int J Chron Obstruct Pulmon Dis; 2022; 17():2711-2722. PubMed ID: 36304969
[TBL] [Abstract][Full Text] [Related]
26. Incidence of venous thromboembolism after standard treatment in patients with epithelial ovarian cancer in Korea.
Shin W; Lee S; Lim MC; Jung J; Kim HJ; Cho H
Cancer Med; 2021 Mar; 10(6):2045-2053. PubMed ID: 33638309
[TBL] [Abstract][Full Text] [Related]
27. Risk factors and treatment of venous thromboembolism in perioperative patients with ovarian cancer in China.
Zhang W; Liu X; Cheng H; Yang Z; Zhang G
Medicine (Baltimore); 2018 Aug; 97(31):e11754. PubMed ID: 30075594
[TBL] [Abstract][Full Text] [Related]
28. Plasminogen activator inhibitor-1, thrombin-antithrombin, and prothrombin fragment F1+2 have higher diagnostic values than D-dimer for venous thromboembolism after TKA.
Yang Y; Feng G; Yan J; Wu L; Wang F; Ding D; Wang H; Jin Q
Clin Appl Thromb Hemost; 2022; 28():10760296221097383. PubMed ID: 35535394
[TBL] [Abstract][Full Text] [Related]
29. Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis?
Shafa A; Watkins AB; McGree ME; Weroha SJ; Wahner Hendrickson AE; Block MS; Langstraat CL; McBane RD; Bakkum-Gamez JN; Kumar A
Gynecol Oncol; 2023 Sep; 176():36-42. PubMed ID: 37442024
[TBL] [Abstract][Full Text] [Related]
30. Surgical treatment of ovarian cancer and early detection of venous thromboembolism.
Maksimović M; Maksimović M; Gojnić M; Maksimović Z; Petković S; Ljubić A; Stefanović A; Jeremić K
Eur J Gynaecol Oncol; 2011; 32(4):415-8. PubMed ID: 21941965
[TBL] [Abstract][Full Text] [Related]
31. [Risk prediction of venous thromboembolism in non-small cell lung cancer patients based on COMPASS-CAT risk assessment model].
Wang YF; Ma F; Liu BL; Yang K; Li JL; Yu L
Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):340-345. PubMed ID: 32375452
[No Abstract] [Full Text] [Related]
32. The timing of venous thromboembolism in ovarian cancer patients: A nationwide Danish cohort study.
Strøm Kahr H; Christiansen OB; Juul Riddersholm S; Gade IL; Torp-Pedersen C; Knudsen A; Thorlacius-Ussing O
J Thromb Haemost; 2021 Apr; 19(4):992-1000. PubMed ID: 33420762
[TBL] [Abstract][Full Text] [Related]
33. Predictive value of inflammatory and coagulation biomarkers for venous thromboembolism in COVID-19 patients.
Hojker M; Tršan J; Tršan U; Gale A; Jerman A; Košuta D
Clin Hemorheol Microcirc; 2023; 83(4):387-395. PubMed ID: 36683498
[TBL] [Abstract][Full Text] [Related]
34. The role of tissue factor pathway inhibitor 2 in the coagulation and fibrinolysis system.
Kobayashi H; Matsubara S; Imanaka S
J Obstet Gynaecol Res; 2023 Jul; 49(7):1677-1683. PubMed ID: 37186495
[TBL] [Abstract][Full Text] [Related]
35. [Risk Factors Associated with Venous Thromboembolism after Lung Cancer Surgery: A Single-center Study].
Cui S; Li H; Tian B; Song C; Hu B
Zhongguo Fei Ai Za Zhi; 2018 Oct; 21(10):753-760. PubMed ID: 30309426
[TBL] [Abstract][Full Text] [Related]
36. [Risk factors of lung cancer complicated with symptomatic venous thromboembolism].
Gong CY; Li ZW; Zhou DX; Yan H; Bao J; Ye RJ; Cao ZL; Gao ZC; Mu XL
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jun; 39(6):454-8. PubMed ID: 27289575
[TBL] [Abstract][Full Text] [Related]
37. Application value of Caprini risk assessment model and elevated tumor-specific D-dimer level in predicting postoperative venous thromboembolism for patients undergoing surgery of gynecologic malignancies.
Shi J; Ye J; Zhuang X; Cheng X; Fu R; Zhao A
J Obstet Gynaecol Res; 2019 Mar; 45(3):657-664. PubMed ID: 30393982
[TBL] [Abstract][Full Text] [Related]
38. High incidence of silent venous thromboembolism before treatment in ovarian cancer.
Satoh T; Oki A; Uno K; Sakurai M; Ochi H; Okada S; Minami R; Matsumoto K; Tanaka YO; Tsunoda H; Homma S; Yoshikawa H
Br J Cancer; 2007 Oct; 97(8):1053-7. PubMed ID: 17895896
[TBL] [Abstract][Full Text] [Related]
39. Venous thromboembolism in epithelial ovarian cancer. A prospective cohort study.
Kahr HS; Christiansen OB; Grove A; Iyer V; Torp-Pedersen C; Knudsen A; Thorlacius-Ussing O
Thromb Res; 2019 Sep; 181():112-119. PubMed ID: 31400621
[TBL] [Abstract][Full Text] [Related]
40. The survival detriment of venous thromboembolism with epithelial ovarian cancer.
Gunderson CC; Thomas ED; Slaughter KN; Farrell R; Ding K; Farris RE; Lauer JK; Perry LJ; McMeekin DS; Moore KN
Gynecol Oncol; 2014 Jul; 134(1):73-7. PubMed ID: 24793732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
